FDA rejects Philip Morris IQOS claims

Jan. 25, 2018 11:59 AM ETPhilip Morris International Inc. (PM)MO, PMBy: Clark Schultz, SA News Editor83 Comments
  • Philip Morris International (PM -4.3%) drops after a FDA panel rejects claims by the company that IQOS products reduce health risks.
  • Shares of Altria (MO -2.7%) are also reacting to the development.
  • The story is still developing. Further updates will be posted.

Recommended For You

Comments (83)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.